REBLOZYL
LIVE

Serial Number

90033523

Owner

Celgene Corporation

Attorney

Xiomara Triana

First Use Date

Nov 8, 2019

Filing Date

Jul 2, 2020

Add to watchlist:

No watchlists yet
View on USPTO

REBLOZYL Trademark

Serial Number: 90033523 • Registration: 6257051

REBLOZYL is a trademark filed by Celgene Corporation on July 2, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

July 2, 2020

Registration Date

January 26, 2021

First Use Anywhere

November 8, 2019

First Use in Commerce

November 8, 2019

Published for Opposition

November 10, 2020

Goods & Services

Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 26, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 26, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 10, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 10, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 21, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 8, 2020 CNSA
ASSIGNED TO EXAMINER
Oct 8, 2020 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Aug 24, 2020 AMPX
ASSIGNED TO LIE
Aug 20, 2020 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 3, 2020 PARI
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 31, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2020 NWOS
NEW APPLICATION ENTERED
Jul 6, 2020 NWAP